Patent details

EP3102225 Title: COMBINATION THERAPY FOR TREATMENT OF HBV INFECTIONS

Basic Information

Publication number:
EP3102225
PCT Application Number:
US2015014663
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157466640
PCT Publication Number:
WO2015120178
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY FOR TREATMENT OF HBV INFECTIONS
French Title of Invention:
POLYTHÉRAPIE POUR LE TRAITEMENT D'INFECTIONS PAR LE VHB
German Title of Invention:
KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON HBV-INFEKTIONEN
SPC Number:

Dates

Filing date:
05/02/2015
Grant date:
25/03/2020
EP Publication Date:
14/12/2016
PCT Publication Date:
13/08/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/03/2020
EP B1 Publication Date:
25/03/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/02/2021
Expiration date:
05/02/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/03/2020
 
 

Name:
Novira Therapeutics Inc.
Address:
Welsh & McKean Roads Mailstop SH 22-2-1, Spring House PA 19477, United States (US)

Inventor

Name:
HARTMAN, George D.
Address:
United States (US)

Priority

Priority Number:
201461936242 P
Priority Date:
05/02/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/167; A61K 31/18; A61K 31/395; A61K 38/21; A61P 31/20;

Publication

European Patent Bulletin

Issue number:
202013
Publication date:
25/03/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages